KIORA PHARMACEUTICALS INC
KPRXNext catalyst
KIO-104
Macular Edema
Get an email about KPRX's next catalysts
Track KIORA PHARMACEUTICALS (KPRX) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
Plus 2 more upcoming events in our data (earnings, Phase 2 readout).See the timeline
3 upcoming, 0 past
KPRX Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | FQ end Sep/2026 | Call: tbd
KIO-104 Phase 2 Est. Readout (KLARITY-1)
Primary completion for KIO-104 trial (NCT06825702) in Macular Edema
SourceKIO-301 Phase 2 Est. Readout (ABACUS-2)
Primary completion for KIO-301 trial (NCT06628947) in Retinitis Pigmentosa
SourceMarket Overview
Stock performance and key metrics
KIO-104
Macular Edema
KIO-201, a Crosslinked Thiolated Carboxymethyl Hyaluronic Acid (CMHA-S)
Persistent Corneal Epithelial Defect
KIO-301
Retinitis Pigmentosa
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
KIO-104 | Phase 2 | Macular Edema | - | - |
KIO-201, a Crosslinked Thiolated Carboxymethyl Hyaluronic Acid (CMHA-S) | Phase 2 | Persistent Corneal Epithelial Defect | - | - |
KIO-301 | Phase 2 | Retinitis Pigmentosa | - | - |
Retinitis Pigmentosa
2 drugs in this indication
Persistent Corneal Epithelial Defect
2 drugs in this indication
Macular Edema
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in KIORA PHARMACEUTICALS INC's drug pipeline?→
CatalystAlert tracks 3 drug candidates in KIORA PHARMACEUTICALS INC's (KPRX) pipeline across Phase 2. Its lead program is KIO-104 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is KIORA PHARMACEUTICALS INC's next FDA catalyst?→
KIORA PHARMACEUTICALS INC's (KPRX) next tracked catalyst is a Phase 2 readout expected November 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track KPRX biotech catalysts?→
Add KPRX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow KIORA PHARMACEUTICALS INC's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.